There are many active research projects accessing and applying shared ADNI data. Use the search above to find specific research focuses on the active ADNI investigations. This information is requested annually as a requirement for data access.
| Principal Investigator | |
| Principal Investigator's Name: | Chi Zhang |
| Institution: | ByteDance Ltd. |
| Department: | Strategy and Investment |
| Country: | |
| Proposed Analysis: | Objectives Our team from Bytedance is devoted to finding therapies for patients suffering diseases with high unmet needs. Alzheimer's disease (AD) is a disabilitating disorder with few effective treatment options. ADNI provides a unique opportunity to study AD with a rich longitudinal collection of patient biomarkers, clinical and genetics. We plan to identify potential therapeutic targets from genetics data and understand their mechanism of action (MOA) through associated biomarkers and clinical traits. Analysis plan - We will identify potential therapeutic candidates by performing association analysis with genetics data. - We will evaluate the identified candidates by integrating associated biomarkers, clinical data and gene expression data. |
| Additional Investigators | |
| Investigator's Name: | Yuli She |
| Proposed Analysis: | Objectives Our team from Bytedance is devoted to finding therapies for patients suffering diseases with high unmet needs. Alzheimer's disease (AD) is a disabilitating disorder with few effective treatment options. ADNI provides a unique opportunity to study AD with a rich longitudinal collection of patient biomarkers, clinical and genetics. We plan to identify potential therapeutic targets from genetics data and understand their mechanism of action (MOA) through associated biomarkers and clinical traits. Analysis plan - We will identify potential therapeutic candidates by performing association analysis with genetics data. - We will evaluate the identified candidates by integrating associated biomarkers, clinical data and gene expression data. |
